Latest Breaking News On - Aridis pharmaceuticals - Page 10 : comparemela.com

Aridis Pharma Up 21% After FDA Grants QIDP Status For AR-301

Shares of Aridis Pharmaceuticals, Inc. (ARDS) are up 21% on Wednesday after the company announced that the FDA has granted a Qualified Infectious Disease Product (QIDP) designation for AR-301.

Aridis pharmaceuticals incAridis pharmaceuticalsQualified infectious disease product

Aridis Pharmaceuticals (ARDS) AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA s Qualified Infectious Diseases Product (QIDP) Designation

Aridis Pharmaceuticals (ARDS) AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA s Qualified Infectious Diseases Product (QIDP) Designation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vu truongDrug administration safetyAridis pharmaceuticalsDrug administrationAridis pharmaceuticals incQualified infectious disease productGenerating antibiotic incentives nowChief executive officerInnovation actDrug omnibus reform actConsolidated appropriations actBiologics license application

Aridis Pharmaceuticals Gets FDA Product Designation for AR-301

By Chris Wack Aridis Pharmaceuticals said Wednesday that the U.S. Food and Drug Administration has granted Qualified Infectious Disease Product Designation.

Chris wackDrug administrationAridis pharmaceuticalsQualified infectious disease product designationBiologics license applicationArticle normalBiotechnology servicesHealthcare life sciencesRegulation government policyCorporate industrial newsContent typesFactiva filtersC amp ampe industry news filterGovernment policyIndustrial newsLife sciences

ARDS Stock Price | Aridis Pharmaceuticals Inc Stock Quote (U S : Nasdaq)

ARDS | Complete Aridis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Etby tomi kilgoreAridis pharmaceuticals incAridis pharmaceuticalsRds analyst estimatesRds earnings estimatesRds share estimatesRds analyst recommendationsRds ratingsRidis pharmaceuticals inc analyst estimatesRidis pharmaceuticals inc earnings estimatesRidis pharmaceuticals inc analyst recommendationsRidis pharmaceuticals inc analyst ratings

Aridis AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA s Qualified Infectious Diseases Product (QIDP) Designation

Aridis AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA s Qualified Infectious Diseases Product (QIDP) Designation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vu truongDrug administrationDrug administration safetyCeoredchip companiessource aridis pharmaceuticals incAridis pharmaceuticals incSerum institute of indiaExchange commissionAridis pharmaceuticalsQualified infectious disease productGenerating antibiotic incentives nowChief executive officerInnovation actDrug omnibus reform actConsolidated appropriations actBiologics license applicationInfectious diseases